Location History:
- Lengerich, DE (2013)
- Weidense, DE (2016)
- Weidenberg, DE (2015 - 2017)
- Teufen, CH (2017 - 2021)
Company Filing History:
Years Active: 2013-2021
Title: Innovations of Andreas Wirth in Cell Treatment Technology
Introduction
Andreas Wirth is a notable inventor based in Weidenberg, Germany. He has made significant contributions to the field of cell treatment technology, holding a total of seven patents. His work focuses on methods and devices that enhance the efficiency of treating adherent cells using electric fields.
Latest Patents
One of his latest patents is a method and device for uniformly treating adherent cells. This invention discloses a method for subjecting adherent cells to at least one electric field. The electric field is generated by applying a voltage to at least two active electrodes, with at least three electrodes provided. The method allows for the generation of a first electric field and a second electric field, where at least one of the previously active electrodes becomes a potential-free electrode during the voltage application. The device associated with this method comprises at least three electrodes connected to a voltage source through switching devices. This innovative approach enables efficient and uniform treatment of adherent cells, allowing for quick and safe switching between active and potential-free electrodes.
Career Highlights
Andreas Wirth is currently employed at Lonza Cologne GmbH, where he continues to develop and refine his inventions. His work has been instrumental in advancing technologies that improve cell treatment processes.
Collaborations
He collaborates with notable colleagues, including Andreas Heinze and Timo Gleissner, contributing to a dynamic research environment that fosters innovation.
Conclusion
Andreas Wirth's contributions to the field of cell treatment technology through his patents and collaborations highlight his role as a leading inventor. His innovative methods and devices are paving the way for advancements in the treatment of adherent cells.